Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
Myocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance. When MI occurs early in life, genetic inheritance is a major component to risk. Previously, rare mutations in low-density lipoprotein (LDL) genes have been shown to contribute to MI risk...
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Journal article |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
2014
|
| _version_ | 1826260133150195712 |
|---|---|
| author | Do, R Stitziel, N Won, H Jørgensen, AB Duga, S Angelica Merlini, P Kiezun, A Farrall, M Goel, A Zuk, O Guella, I Asselta, R Lange, L Peloso, G Auer, P Girelli, D Martinelli, N Farlow, D DePristo, M Roberts, R Stewart, A Saleheen, D Danesh, J Epstein, SE Sivapalaratnam, S |
| author_facet | Do, R Stitziel, N Won, H Jørgensen, AB Duga, S Angelica Merlini, P Kiezun, A Farrall, M Goel, A Zuk, O Guella, I Asselta, R Lange, L Peloso, G Auer, P Girelli, D Martinelli, N Farlow, D DePristo, M Roberts, R Stewart, A Saleheen, D Danesh, J Epstein, SE Sivapalaratnam, S |
| author_sort | Do, R |
| collection | OXFORD |
| description | Myocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance. When MI occurs early in life, genetic inheritance is a major component to risk. Previously, rare mutations in low-density lipoprotein (LDL) genes have been shown to contribute to MI risk in individual families, whereas common variants at more than 45 loci have been associated with MI risk in the population. Here we evaluate how rare mutations contribute to early-onset MI risk in the population. We sequenced the protein-coding regions of 9,793 genomes from patients with MI at an early age (≤50 years in males and ≤60 years in females) along with MI-free controls. We identified two genes in which rare coding-sequence mutations were more frequent in MI cases versus controls at exome-wide significance. At low-density lipoprotein receptor (LDLR), carriers of rare non-synonymous mutations were at 4.2-fold increased risk for MI; carriers of null alleles at LDLR were at even higher risk (13-fold difference). Approximately 2% of early MI cases harbour a rare, damaging mutation in LDLR; this estimate is similar to one made more than 40 years ago using an analysis of total cholesterol. Among controls, about 1 in 217 carried an LDLR coding-sequence mutation and had plasma LDL cholesterol > 190 mg dl(-1). At apolipoprotein A-V (APOA5), carriers of rare non-synonymous mutations were at 2.2-fold increased risk for MI. When compared with non-carriers, LDLR mutation carriers had higher plasma LDL cholesterol, whereas APOA5 mutation carriers had higher plasma triglycerides. Recent evidence has connected MI risk with coding-sequence mutations at two genes functionally related to APOA5, namely lipoprotein lipase and apolipoprotein C-III (refs 18, 19). Combined, these observations suggest that, as well as LDL cholesterol, disordered metabolism of triglyceride-rich lipoproteins contributes to MI risk. |
| first_indexed | 2024-03-06T19:00:48Z |
| format | Journal article |
| id | oxford-uuid:1373d5dc-8e71-4e5f-b5a1-c44eadcbcfb2 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:00:48Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | oxford-uuid:1373d5dc-8e71-4e5f-b5a1-c44eadcbcfb22022-03-26T10:14:04ZExome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1373d5dc-8e71-4e5f-b5a1-c44eadcbcfb2EnglishSymplectic Elements at Oxford2014Do, RStitziel, NWon, HJørgensen, ABDuga, SAngelica Merlini, PKiezun, AFarrall, MGoel, AZuk, OGuella, IAsselta, RLange, LPeloso, GAuer, PGirelli, DMartinelli, NFarlow, DDePristo, MRoberts, RStewart, ASaleheen, DDanesh, JEpstein, SESivapalaratnam, SMyocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance. When MI occurs early in life, genetic inheritance is a major component to risk. Previously, rare mutations in low-density lipoprotein (LDL) genes have been shown to contribute to MI risk in individual families, whereas common variants at more than 45 loci have been associated with MI risk in the population. Here we evaluate how rare mutations contribute to early-onset MI risk in the population. We sequenced the protein-coding regions of 9,793 genomes from patients with MI at an early age (≤50 years in males and ≤60 years in females) along with MI-free controls. We identified two genes in which rare coding-sequence mutations were more frequent in MI cases versus controls at exome-wide significance. At low-density lipoprotein receptor (LDLR), carriers of rare non-synonymous mutations were at 4.2-fold increased risk for MI; carriers of null alleles at LDLR were at even higher risk (13-fold difference). Approximately 2% of early MI cases harbour a rare, damaging mutation in LDLR; this estimate is similar to one made more than 40 years ago using an analysis of total cholesterol. Among controls, about 1 in 217 carried an LDLR coding-sequence mutation and had plasma LDL cholesterol > 190 mg dl(-1). At apolipoprotein A-V (APOA5), carriers of rare non-synonymous mutations were at 2.2-fold increased risk for MI. When compared with non-carriers, LDLR mutation carriers had higher plasma LDL cholesterol, whereas APOA5 mutation carriers had higher plasma triglycerides. Recent evidence has connected MI risk with coding-sequence mutations at two genes functionally related to APOA5, namely lipoprotein lipase and apolipoprotein C-III (refs 18, 19). Combined, these observations suggest that, as well as LDL cholesterol, disordered metabolism of triglyceride-rich lipoproteins contributes to MI risk. |
| spellingShingle | Do, R Stitziel, N Won, H Jørgensen, AB Duga, S Angelica Merlini, P Kiezun, A Farrall, M Goel, A Zuk, O Guella, I Asselta, R Lange, L Peloso, G Auer, P Girelli, D Martinelli, N Farlow, D DePristo, M Roberts, R Stewart, A Saleheen, D Danesh, J Epstein, SE Sivapalaratnam, S Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. |
| title | Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. |
| title_full | Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. |
| title_fullStr | Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. |
| title_full_unstemmed | Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. |
| title_short | Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. |
| title_sort | exome sequencing identifies rare ldlr and apoa5 alleles conferring risk for myocardial infarction |
| work_keys_str_mv | AT dor exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT stitzieln exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT wonh exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT jørgensenab exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT dugas exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT angelicamerlinip exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT kiezuna exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT farrallm exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT goela exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT zuko exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT guellai exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT asseltar exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT langel exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT pelosog exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT auerp exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT girellid exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT martinellin exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT farlowd exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT depristom exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT robertsr exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT stewarta exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT saleheend exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT daneshj exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT epsteinse exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction AT sivapalaratnams exomesequencingidentifiesrareldlrandapoa5allelesconferringriskformyocardialinfarction |